Niagen Bioscience, Inc. Annual Operating Margin in % from 2017 to 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Niagen Bioscience, Inc. quarterly/annual Operating Margin history and growth rate from 2017 to 2024.
  • Niagen Bioscience, Inc. Operating Margin for the quarter ending December 31, 2024 was 7.76 %.
  • Niagen Bioscience, Inc. annual Operating Margin for 2024 was 7.76 %.
  • Niagen Bioscience, Inc. annual Operating Margin for 2023 was -6.7 %, a 74.1% increase from 2022.
  • Niagen Bioscience, Inc. annual Operating Margin for 2022 was -25.9 %, a 35.6% increase from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 7.76 +14.5 Jan 1, 2024 Dec 31, 2024
2023 -6.7 +19.2 +74.1% Jan 1, 2023 Dec 31, 2023
2022 -25.9 +14.3 +35.6% Jan 1, 2022 Dec 31, 2022
2021 -40.1 -6.63 -19.8% Jan 1, 2021 Dec 31, 2021
2020 -33.5 +34.1 +50.4% Jan 1, 2020 Dec 31, 2020
2019 -67.6 +37.5 +35.7% Jan 1, 2019 Dec 31, 2019
2018 -105 -27.9 -36.1% Dec 31, 2017 Dec 31, 2018
2017 -77.3 Jan 1, 2017 Dec 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.